Quick Takeaways
- Bleichroeder LP filed SCHEDULE 13G/A for PRECISION BIOSCIENCES INC Common Shares (DTIL).
- Disclosed ownership: 8.2%.
- Date of event: 31 Dec 2025.
Bleichroeder LP - 31 Dec 2025 SCHEDULE 13G/A Report for PRECISION BIOSCIENCES INC Common Shares (DTIL)
- Filing Manager
- Bleichroeder LP
- Reporting Manager
- Bleichroeder LP
- Symbol
- DTIL
- Shares outstanding
- 23,142,509 shares
- Disclosed Ownership
- 1,900,000 shares
- Ownership
- 8.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Feb 2026, 16:44:48 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Bleichroeder LP disclosed 8.2% ownership in PRECISION BIOSCIENCES INC Common Shares (DTIL) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Aug 2025.
- Current filing was accepted on 13 Feb 2026, 16:44.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Bleichroeder LP | 8.2% | 1,900,000 | 1,900,000 | 0 | Andrew Gundlach | President and CEO | |
| Bleichroeder Holdings LLC | 8.2% | 1,900,000 | 1,900,000 | 0 | Andrew Gundlach | President and CEO | |
| Andrew Gundlach | 8.2% | 1,900,000 | 1,900,000 | 0 | Andrew Gundlach | President and CEO |